FDA Adverse Event Injury Summary report: N

5.0MM TI LOCKING HEAD SCREWSELF-TAPPING 75MM

MDR report key: 4222158 · Received November 3, 2014

Report

Report Number
9612488-2014-10468
Event Type
Injury
Date Received
November 3, 2014
Report Date
August 30, 2014
Manufacturer
SYNTHES BETTLACH
Product Code
KTT
PMA / PMN Number
PK023941
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MI, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

ADDITIONAL NARRATIVE: A MANUFACTURING INVESTIGATION WAS CONDUCTED. THE REPORT INDICATES THAT DHR-CHECK WAS PERFORMED AND NO DISCREPANCIES COULD BE DETECTED. ALL RELEVANT KEY PARAMETERS WERE EVALUATED AND MET THE SPECIFICATIONS AND ALSO THE RESULT OF THE DHR- CHECK CONFIRMED TO THE REQUIRED MANUFACTURING PARAMETERS. THEREFORE THE COMPLAINT IS FROM MANUFACTURING- POINT OF VIEW RATED AS NOT VALID. DEVICE WAS USED FOR TREATMENT, NOT DIAGNOSIS. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.

Additional Manufacturer Narrative · 1

ADDITIONAL PATIENT ID: (B)(6). SUBJECT DEVICE HAS BEEN RECEIVED AND IS CURRENTLY IN THE EVALUATION PROCESS. A DEVICE HISTORY REVIEW WAS CONDUCTED. THE REPORT INDICATES THAT NO NCRS WERE GENERATED DURING PRODUCTION. REVIEW OF THE DEVICE HISTORY RECORD SHOWED THAT THERE WERE NO ISSUES DURING THE MANUFACTURE OF THE PRODUCT THAT WOULD CONTRIBUTE TO THIS COMPLAINT CONDITION. DEVICE WAS USED FOR TREATMENT, NOT DIAGNOSIS. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE SCREWS BROKE POST OPERATIVELY. A REVISION SURGERY WAS PERFORMED TO REMOVE THE DAMAGED PARTS. THIS IS REPORT NUMBER 1 OF 7 FOR (B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
702139 5.0MM TI LOCKING HEAD SCREWSELF-TAPPING 75MM APPLIANCE,FIXATION,NAIL KTT SYNTHES BETTLACH 8026332

Patients

Seq Age Sex Outcome Treatment
1 34 YR Required Intervention